COHEN JONATHAN M enters 20/20 BIOLABS, INC. with 1.37M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/19/2026ACC: 0001213900-26-018516
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2026
1.37M
Baseline shares
100% direct
1.37M
Direct ownership
1 position
513K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.37M
Total
1.37M direct1.37M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.37M | Direct |
| Total | 1.37M | 1.37M direct |
Derivative Holdings2
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
125K
Shares owned
N/A
Exercise price
2.55
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
388K
Shares owned
N/A
Exercise price
1.74
Expiration
—
Exercise window
—
Total
Underlying
513K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock | 2.55 | — | — | 125K | N/A |
| Stock Option Direct | Common Stock | 1.74 | — | — | 388K | N/A |
| Total | 513K | 0.00 | ||||